Pharming has received acceptance from both the EMA and FDA for the accelerated review of leniolisib. The new drug is anticipated to generate significantly more revenue compared to its current profitable drug Ruconest. While the company has been profitable for the past years, it needed to find new sources of income to be able to grow the value of the company. The...
Pharming Group - 30d expiry- We look to Sell a break of 0.934 (stop at 0.993)
Short term bias has turned negative.
Daily signals are mildly bearish.
A higher correction is expected.
We are trading at overbought extremes.
0.936 has been pivotal.
A break of 0.936 is needed to confirm follow through negative momentum.
There is no clear indication that the...
After visiting the support for the 3rd time it only had a short and weak rally up. I think we will visit the 50 cents soon. This could be a good oppertunity to buy in. DCA from 60 cents towards the 0.618 , or 38 cents....the golden pocket
Pharming is a company with good fundamentals and now also available on the NASDAQ via a ADR (10 stocks). Take a look to the company.
Technical Analyse:
After it touched the 200 EMA you can see the big push to the North. My expectation is that this stock will go further North up, probably at least to it's last resistance at 1,46€.
I will keep it simple, because...
Hello all,
Here another TA of me, this time on the stock PHARMING.
Its a very interesting company, i would advice you to dive in the fundamentals for further information. I will just show the possibilities with TA.
Before you choose to buy and hold a stock, always do your homework on the fundamentals. TA can help you by choosing a good moment and price to buy...
Pharming group holdings has been hold back twice in history at around 1.6, i have been watching the MAC D and Stochastic indicator on the daily, they both show interesting signals such as on the macd: Descending red with ascending green, this would at least tell me a new attempt of breaking 1.61 is within a week.
Stochastic on the daily is getting a positive...
Half year results coming up for pharming and seems to be breaking out of the triangle to the upside. First target 1 EUR.
- MACD crossover to bullish side
- RSI crawling up from lower
Risk: Low
Please be advised that this is only an idea, so you are responsible for any losses yourself.
Dear followers,
First of all, many thanks for following and liking my ideas. As promised I provide you with some penny stocks today, but for the most part I keep focusing on the crypto analyses.
Education:
Do you know people who had to leave their home...
